InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: InTheTrenches post# 510

Wednesday, 02/08/2017 10:03:09 AM

Wednesday, February 08, 2017 10:03:09 AM

Post# of 21531
Wait, hold up, safety, tolerability, and PK/PD all proven from administration of just ONE dose in 9 patients? Seriously? Just one dose? Did they run out the drug? I mean, what the _____? And still, NO data from those 3 compassionate use miracle patients. So, what, are they back to painting masterpieces, playing the piano, and playing golf after their two shots? Man this company seems confident without releasing any human data. 3 month data means nothing. All the approved drugs on the market show improvement at 3 months, even 6 months. Does that make them cures too? I'd like to see how these patients do on the synthetic version, whenever that is completed, for a year or more of administration (do we even know when synthetic version is estimated to be completed? Will these trials have to be redone with the synthetic version before approval?) But Neurotrope's Ph 2b is just 3 months long! What is that, like two shots? Shouldn't they be doing trials that last a year? Where Alzheimers drugs fall down is after the 6-12 month window, after the drug has been started.

Statins are known to actually CAUSE dementia btw. But I'm guessing it takes more than just 1 or 2 doses to see that connection
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News